AP NEWS

Bronchopulmonary Dysplasia - Pipeline Insight, 2019 - ResearchAndMarkets.com

January 22, 2019

DUBLIN--(BUSINESS WIRE)--Jan 22, 2019--The “Bronchopulmonary Dysplasia - Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bronchopulmonary Dysplasia development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

Clinical Non-clinical Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Bronchopulmonary Dysplasia

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Bronchopulmonary Dysplasia

The report assesses the active Bronchopulmonary Dysplasia pipeline products by developmental stage, product type, molecule type, and administration route.

Topics Covered

1. Report Introduction

2. Bronchopulmonary Dysplasia Overview

3. Pipeline Therapeutics

4. Comparative Analysis

5. Products in Clinical Stage

6. Products in Pre-Clinical & Discovery Stage

7. Therapeutic Assessment

8. Inactive Products

Companies Featured

Airway Therapeutics LLC Syntrix Biosystems Inc Chiesi Farmaceutici SpA MediPost Co Ltd Meridigen Biotech Co Ltd Therabron Therapeutics Inc

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/hnvsw6/bronchopulmonary?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190122005468/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Respiratory Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/22/2019 06:47 AM/DISC: 01/22/2019 06:47 AM

http://www.businesswire.com/news/home/20190122005468/en

AP RADIO
Update hourly